Advances in understanding ischemic acute kidney injury

BMC Medicine

Volumn 9, Issue , 2011, Pages

  Munshi, Raj ^a   Hsu, Christine ^a   Himmelfarb, Jonathan ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 PHENYL 5 TRIFLUOROMETHYL 2 THIENYL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1;

ACUTE KIDNEY FAILURE; CHRONIC KIDNEY DISEASE; DISEASE COURSE; HUMAN; KIDNEY ISCHEMIA; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; ANIMAL; ARTICLE; CHRONIC KIDNEY FAILURE; ISCHEMIA; ISCHEMIC PRECONDITIONING; METABOLISM; PATHOLOGY; REPERFUSION INJURY;

ACUTE KIDNEY INJURY; ANIMALS; DISEASE PROGRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; ISCHEMIA; ISCHEMIC PRECONDITIONING; KIDNEY FAILURE, CHRONIC; REPERFUSION INJURY;

EID: 79251627609     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-9-11     Document Type: Review

References (44)

1. Lanugos O, Wald R, O'Bell JW, Price L, Pereira BJ, Jaber BL. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol 2006, 1:43-51. 10.2215/CJN.00220605, 17699189.
2. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C, . Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294:813-818. 10.1001/jama.294.7.813, 16106006, Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators.
3. Just A. Mechanisms of renal blood flow autoregulation: dynamics and contributions. Am J Physiol Regul Integr Comp Physiol 2007, 292:R1-R17.
4. Janssen WM, Beekhuis H, de Bruin R, de Jong PE, de Zeeuw D. Noninvasive measurement of intrarenal blood flow distribution: kinetic model of renal 123I-hippuran handling. Am J Physiol 1995, 269:F571-F580.
5. Dagher PC, Herget-Rosenthal S, Ruehm SG, Jo SK, Star RA, Agarwal R, Molitoris BA. Newly developed techniques to study and diagnose acute renal failure. J Am Soc Nephrol 2003, 14:2188-2198. 10.1097/01.ASN.0000079790.91292.4A, 12874475.
6. Sutton TA. Alteration of microvascular permeability in acute kidney injury. Microvasc Res 2009, 77:4-7. 10.1016/j.mvr.2008.09.004, 2680138, 18938184.
7. Legrand M, Mik EG, Johannes T, Payen D, Ince C. Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Mol Med 2008, 14:502-516. 10.2119/2008-00006.Legrand, 2386087, 18488066.
8. Rehm M, Bruegger D, Christ F, Conzen P, Thiel M, Jacob M, Chappell D, Stoeckelhuber M, Welsch U, Reichart B, Peter K, Becker BF. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007, 116:1896-1906. 10.1161/CIRCULATIONAHA.106.684852, 17923576.
9. Goldstein SL, Devarajan P. Progression from acute kidney injury to chronic kidney disease: a pediatric perspective. Adv Chronic Kidney Dis 2008, 15:278-283. 10.1053/j.ackd.2008.04.007, 2481383, 18565478.
10. Sinha R, Nandi M, Tullus K, Marks SD, Taraphder A. Ten-year follow-up of children after acute renal failure from a developing country. Nephrol Dial Transplant 2009, 24:829-833. 10.1093/ndt/gfn539, 18852189.
11. Askenazi DJ, Feig DI, Graham NM, Hui-Stickle S, Goldstein SL. 3-5 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int 2006, 69:184-189. 10.1038/sj.ki.5000032, 16374442.
12. Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009, 53:961-973. 10.1053/j.ajkd.2008.11.034, 2726041, 19346042.
13. Fine LG, Orphanides C, Norman JT. Progressive renal disease: the chronic hypoxia hypothesis. Kidney Int Suppl 1998, 65:S74-S78.
14. Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 2010, 21:212-222. 10.1681/ASN.2008121226, 20019167.
15. Fine LG, Norman JT. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. Kidney Int 2008, 74:867-872. 10.1038/ki.2008.350, 18633339.
16. Bohle A, Mackensen-Haen S, Wehrmann M. Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press Res 1996, 19:191-195. 10.1159/000174072, 8887259.
17. Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, Schreiner GF, Johnson RJ. Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 2002, 13:806-816. 10.1097/01.ASN.0000034910.58454.FD, 11856789.
18. Basile DP, Donohoe D, Roethe K, Osborn JL. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 2001, 281:F887-F899.
19. Matsumoto M, Makino Y, Tanaka T, Tanaka H, Ishizaka N, Noiri E, Fujita T, Nangaku M. Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats. J Am Soc Nephrol 2003, 14:1825-1832. 10.1097/01.ASN.0000074239.22357.06, 12819242.
20. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to endstage renal failure. J Am Soc Nephrol 2006, 17:17-25. 10.1681/ASN.2005070757, 16291837.
21. Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004, 5:343-354. 10.1038/nrm1366, 15122348.
22. Tanaka T, Nangaku M. The role of hypoxia, increased oxygen consumption, and hypoxiainducible factor-1 alpha in progression of chronic kidney disease. Curr Opin Nephrol Hypertens 2010, 19:43-50. 10.1097/MNH.0b013e3283328eed, 19779337.
23. Song YR, You SJ, Lee YM, Chin HJ, Chae DW, Oh YK, Joo KW, Han JS, Na KY. Activation of hypoxia-inducible factor attenuates renal injury in rat remnant kidney. Nephrol Dial Transplant 2010, 25:77-85. 10.1093/ndt/gfp454, 19737871.
24. Nangaku M, Eckardt KU. Hypoxia and the HIF system in kidney disease. J Mol Med 2007, 85:1325-1330. 10.1007/s00109-007-0278-y, 18026918.
25. Ma D, Lim T, Xu J, Tang H, Wan Y, Zhao H, Hossain M, Maxwell PH, Maze M. Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1α activation. J Am Soc Nephrol 2009, 20:713-720. 10.1681/ASN.2008070712, 2663824, 19144758.
26. Bernhardt WM, Gottmann U, Doyon F, Buchholz B, Campean V, Schodel J, Reisenbuechler A, Klaus S, Arend M, Flippin L, Willam C, Wiesener MS, Yard B, Warnecke C, Eckardt KU. Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model. Proc Natl Acad Sci USA 2009, 106:21276-21281. 10.1073/pnas.0903978106, 2795511, 19934037.
27. Hsieh MM, Linde NS, Wynter A, Metzger M, Wong C, Langsetmo I, Lin A, Smith R, Rodgers GP, Donahue RE, Klaus SJ, Tisdale JF. HIF prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques. Blood 2007, 110:2140-2147. 10.1182/blood-2007-02-073254, 1976368, 17557894.
28. Higgins DF, Biju MP, Akai Y, Wutz A, Johnson RS, Haase VH. Hypoxic induction of Ctgf is directly mediated by Hif-1. Am J Physiol Renal Physiol 2004, 287:F1223-F1232. 10.1152/ajprenal.00245.2004, 15315937.
29. Higgins DF, Kimura K, Bernhardt WM, Shrimanker N, Akai Y, Hohenstein B, Saito Y, Johnson RS, Kretzler M, Cohen CD, Eckardt KU, Iwano M, Haase VH. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 2007, 117:3810-3820. 2082142, 18037992.
30. Heddleston JM, Li Z, Lathia JD, Bao S, Hjelmeland AB, Rich JN. Hypoxia inducible factors in cancer stem cells. Br J Cancer 2010, 102:789-795. 10.1038/sj.bjc.6605551, 20104230.
31. Bonventre JV, Zuk A. Ischemic acute renal failure: an inflammatory disease?. Kidney Int 2004, 66:480-485. 10.1111/j.1523-1755.2004.761_2.x, 15253693.
32. Villanueva S, Cespedes C, Vio CP. Ischemic acute renal failure induces the expression of a wide range of nephrogenic proteins. Am J Physiol Regul Integr Comp Physiol 2006, 290:R861-R870.
33. Awad AS, Ye H, Huang L, Li L, Foss FW, Macdonald TL, Lynch KR, Okusa MD. Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol 2006, 290:F1516-F1524. 10.1152/ajprenal.00311.2005, 16403835.
34. Lien YH, Yong KC, Cho C, Igarashi S, Lai LW. S1P1-selective agonist, SEW2871, ameliorates ischemic acute renal failure. Kidney Int 2006, 69:1601-1608. 10.1038/sj.ki.5000360, 16572108.
35. Bajwa A, Jo SK, Ye H, Huang L, Dondeti KR, Rosin DL, Haase VH, Macdonald TL, Lynch KR, Okusa MD. Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury. J Am Soc Nephrol 2010, 21:955-965. 10.1681/ASN.2009060662, 20338995.
36. Wei Q, Bhatt K, He HZ, Mi QS, Haase VH, Dong Z. Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 2010, 21:756-761. 10.1681/ASN.2009070718, 20360310.
37. Park KM, Chen A, Bonventre JV. Prevention of kidney ischemia/reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J Biol Chem 2001, 276:11870-11876. 10.1074/jbc.M007518200, 11150293.
38. Kinsey GR, Huang L, Vergis AL, Li L, Okusa MD. Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney. Kidney Int 2010, 77:771-780. 10.1038/ki.2010.12, 2912287, 20164824.
39. Lee HT, Emala CW. Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A1 and A3 receptors. Am J Physiol Renal Physiol 2000, 278:F380-F387.
40. Ali ZA, Callaghan CJ, Lim E, Ali AA, Nouraei SA, Akthar AM, Boyle JR, Varty K, Kharbanda RK, Dutka DP, Gaunt ME. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation 2007, 116(11 Suppl):I98-I105.
41. Rahman IA, Mascaro JG, Steeds RP, Frenneaux MP, Nightingale P, Gosling P, Townsend P, Townend JN, Green D, Bonser RS. Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment?. Circulation 2010, 122(11 Suppl):S53-S59. 10.1161/CIRCULATIONAHA.109.926667, 20837926.
42. Venugopal V, Laing CM, Ludman A, Yellon DM, Hausenloy D. Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials. Am J Kidney Dis 2010, 56:1043-1049. 10.1053/j.ajkd.2010.07.014, 2991586, 20974511.
43. Wenwu Z, Debing Z, Renwei C, Jian L, Guangxian Y, Pingbo L, Xinmin Z. Limb ischemic preconditioning reduces heart and lung injury after an open heart operation in infants. Pediatr Cardiol 2010, 31:22-29. 10.1007/s00246-009-9536-9, 19787388.
44. Shimizu M, Saxena P, Konstantinov IE, Cherepanov V, Cheung MM, Wearden P, Zhangdong H, Schmidt M, Downey GP, Redingote AN. Remote ischemic preconditioning decreases adhesion and selectively modifies functional responses of human neutrophils. J Surg Res 2010, 158:155-161. 10.1016/j.jss.2008.08.010, 19540519.